- Home
- NRK vs BGM Comparison
NRK vs BGM Comparison
Compare NRK & BGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRK
- BGM
- Stock Information
- Founded
- NRK 2002
- BGM 2019
- Country
- NRK United States
- BGM China
- Employees
- NRK N/A
- BGM N/A
- Industry
- NRK Trusts Except Educational Religious and Charitable
- BGM
- Sector
- NRK Finance
- BGM
- Exchange
- NRK Nasdaq
- BGM NYSE
- Market Cap
- NRK 922.1M
- BGM 1.0B
- IPO Year
- NRK N/A
- BGM 2021
- Fundamental
- Price
- NRK $10.06
- BGM $11.03
- Analyst Decision
- NRK
- BGM
- Analyst Count
- NRK 0
- BGM 0
- Target Price
- NRK N/A
- BGM N/A
- AVG Volume (30 Days)
- NRK 187.3K
- BGM 31.0K
- Earning Date
- NRK 01-01-0001
- BGM 05-20-2025
- Dividend Yield
- NRK 4.10%
- BGM N/A
- EPS Growth
- NRK N/A
- BGM N/A
- EPS
- NRK N/A
- BGM N/A
- Revenue
- NRK N/A
- BGM $25,097,951.00
- Revenue This Year
- NRK N/A
- BGM N/A
- Revenue Next Year
- NRK N/A
- BGM N/A
- P/E Ratio
- NRK N/A
- BGM N/A
- Revenue Growth
- NRK N/A
- BGM N/A
- 52 Week Low
- NRK $8.95
- BGM $2.70
- 52 Week High
- NRK $11.09
- BGM $14.78
- Technical
- Relative Strength Index (RSI)
- NRK 49.17
- BGM 50.51
- Support Level
- NRK $10.02
- BGM $10.17
- Resistance Level
- NRK $10.14
- BGM $11.82
- Average True Range (ATR)
- NRK 0.08
- BGM 0.63
- MACD
- NRK 0.03
- BGM -0.03
- Stochastic Oscillator
- NRK 78.35
- BGM 54.21
About NRK Nuveen New York AMT-Free Quality Municipal Income Fund
Nuveen New York AMT-Free Quality Municipal Income Fund is a closed-end investment company. Its investment objective is to provide current income exempt from regular federal, New York State, and New York City income taxes and from the federal alternative minimum tax applies to individuals and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About BGM QILIAN INTERNATIONAL HLDG GROUP LTD
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.